Results 291 to 300 of about 407,965 (429)

Gender differences in outcomes among diabetic patients undergoing percutaneous coronary interventions Aaron D. Kugelmass, Sameer Mehta, April W. Simon, Lynn G. Tarkington, Salvatore Battaglia, Steven D. Culler, Edmund R. Becker. University of Oklahoma, Oklahoma City, OK, Emory University Rollins School of Public Health, Atlanta, GA

, 2001

openalex   +1 more source

Comparative outcomes of percutaneous coronary interventions in diabetics vs non-diabetics with prior coronary artery bypass grafting [PDF]

, 2002
V Mathew, Stephanie H. Wilson, Gregory W. Barsness, RL Frye, Ryan J. Lennon, David R. Holmes   +5 more
openalex   +1 more source

Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re‐PHIRE

ESC Heart Failure, Volume 12, Issue 3, Page 1956-1964, June 2025.
Abstract Aims Despite receiving guideline‐directed medical heart failure (HF) therapy, patients with pulmonary hypertension associated with left heart disease (PH‐LHD) experience higher mortality and hospitalization rates than the general HF population.
Marcin Ufnal, Kathleen Connolly, Marcus Millegard, Elena Surkova, Marco Guazzi, Diana Bonderman, Justin Ezekowitz, Finn Gustafsson, Michał Ciurzyński, Raquel López Vilella, Tariq Ahmad, Roy Gardner, Pavel Jansa, Sandra van Wijk, Koichiro Kinugawa, Erik Björklund, Zhi‐Cheng Jing, Stephan Rosenkranz   +17 more
wiley   +1 more source

Dual Antiplatelet Therapy Duration Following Percutaneous Coronary Intervention: Time for a Change. [PDF]

J Soc Cardiovasc Angiogr Interv
Kereiakes DJ.
europepmc   +1 more source

The effects of beta blocker therapy in patients with acute coronary syndromes undergoing percutaneous intervention: EPIC, CAPTURE, and RAPPORT data bases Byron K. Ellis, A.M. Lincoff, Shelly Sapp. Cleveland Clinic Foundation, Cleveland, OH

, 2001

openalex   +1 more source

A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass [PDF]

, 2002
A. Michael Borkon, Gregory Muehlebach, John A. House, Steven P. Marso, John A. Spertus   +4 more
openalex   +1 more source

Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure

ESC Heart Failure, Volume 12, Issue 3, Page 2023-2033, June 2025.
Abstract Aims Dapagliflozin (DAPA), a sodium‐glucose co‐transporter 2 inhibitor, has been shown to reduce cardiovascular mortality among patients with chronic heart failure. We aimed to evaluate the impact on a worsening renal function (WRF) by adding DAPA as compared to standard decongestive therapy with loop diuretics alone.
Shodai Kawanami, Yasuyuki Egami, Masaru Abe, Mizuki Osuga, Hiroaki Nohara, Kohei Ukita, Akito Kawamura, Koji Yasumoto, Naotaka Okamoto, Yasuharu Matsunaga‐Lee, Masamichi Yano, Masami Nishino   +11 more
wiley   +1 more source

Metaanálisis en cirugía cardiovascular: una herramienta estadística muy valiosa

Cirugía Cardiovascular
Stefano Urso, Victor Dayan
doaj  

Primary Percutaneous Coronary Intervention in Single Ostium Coronary Arteries: Challenges and Considerations. [PDF]

Cureus
Saleem MW, Ullah S, Zaib UK, Amjad M, Ullah I, Khan MI.   +5 more
europepmc   +1 more source

Staged versus non staged approach for multivessel percutaneous coronary interventions Andrea S. Abizaid, Roxana Mehran, Alexandre Abizaid, George Dangas, Luis Gruberg, Augusto D. Pichard, Ron Waksman, Lowell F. Satler, Kenneth M. Kent, Alexandra J. Lansky, Gregg W. Stone, Martin B. Leon. Cardiovascular Research Foundation, New York, NY, Washington Hospital Center, Washington, DC

, 2001

openalex   +1 more source